Psychiatric healthcare resource utilization following initiation of aripiprazole once-monthly: a retrospective real-world study

Heidi C. Watersa Otsuka Pharmaceutical Development & Commercialization, Inc, Princeton, NJ, USACorrespondence[email protected]

Maelys Touyab Lundbeck, Deerfield, IL, USA

Soon Nan Weec Holmusk Technologies Inc, New York, NY, USA

Michelle Ngc Holmusk Technologies Inc, New York, NY, USA

Simran Thadanic Holmusk Technologies Inc, New York, NY, USA

Subina Surendranc Holmusk Technologies Inc, New York, NY, USA

Miguel Renteríac Holmusk Technologies Inc, New York, NY, USA

A. John Rushd Department of Psychiatry, Duke-National University of Singapore (NUS), Singapore;e Duke University School of Medicine, Durham, NC, USA;f Texas Tech Health Sciences Center, Odessa, TX, USA

Rashmi Patelc Holmusk Technologies Inc, New York, NY, USA;g King’s College London, London, UK

Joydeep Sarkarc Holmusk Technologies Inc, New York, NY, USA

Heather M. Fitzgeraldb Lundbeck, Deerfield, IL, USA

Xue Hana Otsuka Pharmaceutical Development & Commercialization, Inc, Princeton, NJ, USA

show all

Psychiatric healthcare resource utilization following initiation of aripiprazole once-monthly: a retrospective real-world study

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Psychiatric healthcare resource utilization following initiation of aripiprazole once-monthly: a retrospective real-world study

Citations (0)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date